Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo

J Neurol. 1993 Dec;241(2):68-74. doi: 10.1007/BF00869766.

Abstract

The brain morphology and chemistry of seven children with late infantile (4/7) and juvenile (3/7) forms of metachromatic leukodystrophy (MLD) were investigated by magnetic resonance imaging (MRI) and localized proton magnetic resonance spectroscopy (MRS). Patients who were examined at least 6 months after the onset of symptoms (6/7) had severe leukodystrophic changes on MRI. Proton MRS revealed a marked reduction of the neuronal marker N-acetylaspartate in white and grey matter and elevated lactate in demyelinated areas. In contrast to other leukodystrophies MLD patients showed a generalized increase of brain myo-inositol (2- to 3-fold in white matter), indicating a specific role in the pathophysiology of demyelination in MLD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Aspartic Acid / analogs & derivatives
  • Aspartic Acid / analysis
  • Bone Marrow Transplantation
  • Brain / metabolism
  • Brain / pathology
  • Brain Chemistry*
  • Child
  • Child, Preschool
  • Choline / analysis
  • Creatine / analysis
  • Female
  • Glutamates / analysis
  • Glutamic Acid
  • Humans
  • Inositol / analysis
  • Lactates / analysis
  • Lactic Acid
  • Leukodystrophy, Metachromatic / metabolism*
  • Leukodystrophy, Metachromatic / pathology
  • Leukodystrophy, Metachromatic / surgery
  • Magnetic Resonance Imaging*
  • Male
  • Phosphocreatine / analysis
  • Postoperative Period

Substances

  • Glutamates
  • Lactates
  • Phosphocreatine
  • Aspartic Acid
  • Lactic Acid
  • Glutamic Acid
  • Inositol
  • N-acetylaspartate
  • Creatine
  • Choline